February 04, 2026 09:12 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Justice crying behind closed doors’: Mamata Banerjee slams ECI in Supreme Court, CJI Kant assures solution | Mummy, Papa, sorry: Three sisters jump to death after parents object to online gaming | Supreme Court raps Meta, WhatsApp: ‘Theft of private information, won’t allow its use’ | ‘Completely surrendered’: Congress slams Modi after Trump’s trade deal move | PM Modi thanks 'dear friend' Trump for tariff reduction, hails strong US–India partnership | Trump announces US–India trade deal, lowers reciprocal tariffs to 18% | After Budget mayhem, bulls return: Sensex, Nifty stage sharp recovery | Dalai Lama wins first Grammy at 90 | Firing outside Rohit Shetty’s Mumbai home: 4 arrested, Bishnoi Gang link emerges | Female suicide attackers emerge at centre of deadly BLA assaults that rocked Pakistan’s Balochistan
COVID19
Pixabay

US centers for disease control backs panel proposal for initial COVID-19 vaccine doses

| @indiablooms | Dec 04, 2020, at 02:59 pm

Washington/Sputnik: The US Centers for Disease Control and Prevention (CDC) adopted recommendations from an advisory panel that the first doses of a coronavirus vaccine be reserved for elderly care residents and health workers, according to a press release.

''[CDC Director Robert] Redfield supports their recommendations and has signed the memo and accepted these interim recommendations,'' the release said on Thursday.

On Tuesday, the CDC’s Advisory Committee on Immunization Practices recommended that initial vaccinations target 3 million residents in elderly care facilities and a portion of the nation’s 21 million healthcare workers.

Health workers such as nurses, whose jobs routinely place them within six feet of other people, would be first to receive the vaccine followed by workers able to follow CDC social distancing guidelines, the Advisory Committee said.

Vaccines made by Pfizer and Moderna have applied for emergency use authorization from the US Food and Drug Administration amid expectations of quick approval with first doses administered later this month. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.